PT  - JOURNAL ARTICLE
AU  - Mettler, Sofia K.
AU  - Kim, Jihoo
AU  - Maathuis, Marloes H.
TI  - Diagnostic serial interval as a novel indicator for contact tracing effectiveness exemplified with the SARS-CoV-2/COVID-19 outbreak in South Korea
AID  - 10.1101/2020.05.05.20070946
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.05.05.20070946
4099  - http://medrxiv.org/content/early/2020/07/22/2020.05.05.20070946.short
4100  - http://medrxiv.org/content/early/2020/07/22/2020.05.05.20070946.full
AB  - BACKGROUND The clinical onset serial interval is often used as a proxy for the transmission serial interval of an infectious disease. For SARS-CoV-2/COVID-19, data on clinical onset serial intervals is limited, since symptom onset dates are not routinely recorded and do not exist in asymptomatic carriers.METHODS We define the diagnostic serial interval as the time between the diagnosis dates of the infector and infectee. Based on the DS4C project data on SARS-CoV-2/COVID-19 in South Korea, we estimate the means of the diagnostic serial interval, the clinical onset serial interval and the difference between the two. We use the balanced cluster bootstrap method to construct 95RESULTS The mean of the diagnostic serial interval was estimated to be 3.63 days (95CONCLUSIONS The relatively short diagnostic serial intervals of SARS-CoV-2/COVID-19 in South Korea are likely due to the country’s extensive efforts towards contact tracing. We suggest the mean diagnostic serial interval as a new indicator for the effectiveness of a country’s contact tracing as part of the epidemic surveillance.Competing Interest StatementThe authors have declared no competing interest.Funding StatementWe declare no funding sources for writing this manuscript.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesOur research is based on the publicly accessible data which are part of the DS4C project. The data set used in the study will be made available once the article is peer-reviewed and published.